
RAPID DETECTION OF FETAL ANEUPLOIDIES
BY QUANTITATIVE FLUORESCENT-POLYMERASE
CHAIN REACTION FOR PRENATAL DIAGNOSIS
IN THE TURKISH POPULATION Guzel AI, Yilmaz MB, Demirhan O, Pazarbasi A, Kocaturk-Sel S, Erkoc MA,
Inandiklioglu N, Ozgunen FT, Sariturk C *Corresponding Author: Associate Professor Ali Irfan Guzel, Department of Medical Biology and
Genetics, Faculty of Medicine, Rize University, 53100, Rize, Turkey; Tel.: +90-464-212-30-09; Fax: +90-
464-212-30-15; E-mail: aliirfanguzel@hotmail.com page: 11 download article in pdf format
|
Abstract
Prenatal diagnosis is testing for diseases or
conditions in a fetus or embryo before it is born.
It employs a variety of techniques to determine the
health and condition of an unborn fetus. The main
goal of this process is to perform prenatal diagnosis
at the earliest possible stage of gestation. In this regard,
quantitative fl uorescent-polymerase chain reaction
(QF-PCR), a novel technique that is fast and
reliable, was employed to detect aneuploidies (13,
18, 21, X and Y) without the need of the time-consuming
culturing process. The QF-PCR method can
detect fi ve different chromosome aneuploidies with
98.6% accuracy. In this study, 1874 amniotic fl uid
samples of pregnant subjects, who were referred to
the Department of Medical Biology and Genetics,
Adana, Turkey (molecular biology section), were
analyzed with the QF-PCR technique by employing
27 short tandem repeat (STR) markers to detect
chromosomes 13, 18, 21, X and Y aneuploidies.
We detected 31 subjects (1.7%) with aneuploidies
or euploidies out of the 1874 subjects. The average
age of the pregnant subjects was 32 (range: 14-49).
Abnormal karyotypes detected were as follows:
47,XX,+21 (19.4%, 6/31), 47,XY,+21 (48.4%,
15/31), 48,XXX,+21 (3.2%, 1/31), 69,XXX (3.2%,
1/31), 47,XY,+13 (3.2%, 1/31), 47,XXY (9.6%,
3/31), 47,XXX (9.6%, 3/31) and 45,X (3.2%, 1/31).
Moreover, some STR markers were found to be
more specifi c to the Turkish population. In conclusion,
QF-PCR can be regarded as an alternative
method of conventional cytogenetic analysis as it is
a rapid and reliable method; however, in most cases
it is required to be supported or validated with conventional
cytogenetic karyotyping and some STR
markers employed for QF-PCR can be more informative
for a given population.
|
|
|
|



 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|